​

Onconetix (ONCO) Revenue & Revenue Breakdown

OverviewFinancialsChart

Onconetix Revenue Highlights

Latest Revenue (Y)

$58.47K

Latest Revenue (Q)

$406.86K

Main Geography (Y)

European Union

Onconetix Revenue by Period

Onconetix Revenue by Year

DateRevenueChange
2023-12-31$58.47K100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Onconetix generated $58.47K in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Onconetix Revenue by Quarter

DateRevenueChange
2024-09-30$406.86K-42.28%
2024-06-30$704.85K0.63%
2024-03-31$700.43K1098.04%
2023-12-31$58.47K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-03-31--

Onconetix generated $406.86K in revenue during Q3 2024, up -42.28% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Onconetix Revenue Breakdown

Onconetix Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 25Sep 24Jun 24Mar 24
Product$100.00K$100.00K$100.00K$100.00K

Onconetix's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Product (100.00%).

Onconetix Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23
UNITED STATES$63.12K-
European Union$2.44M-
SWITZERLAND-$58.47K

Onconetix's latest annual revenue breakdown by geography, as of Dec 24: European Union (97.48%), and UNITED STATES (2.52%).

Quarterly Revenue by Country

CountryJun 25Mar 25
European Union$104.21K$94.38K

Onconetix's latest quarterly revenue breakdown by geography, as of Jun 25: European Union (100.00%).

Onconetix Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CDTCDT Equity$2.46B$671.99M
ADTXAditxt$133.99M$1.02K
ONCOOnconetix$58.47K$406.86K
CARMCarisma Therapeutics-$3.73M
ASBPAspire Biopharma--
REVBRevelation Biosciences--
ENVBEnveric Biosciences--
JSPRJasper Therapeutics--
SLXNSilexion Therapeutics--

ONCO Revenue FAQ

What is Onconetix’s yearly revenue?

Onconetix's yearly revenue for 2023 was $58.46K, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ONCO's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Onconetix’s quarterly revenue?

Onconetix's quarterly revenue for Q3 2024 was $406.86K, a -42.28% decrease from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $704.85K, a 0.63% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). ONCO's quarterly revenue for Q1 2024 was $700.43K, a 1098.04% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Onconetix’s revenue growth rate?

Onconetix's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.